MMP9 and neoplasm: In addition, when PRISM was used to perform longitudinal tracking of tumor progression in individual animals, the 64Cu-PRISM PET measurement of liver tumor expansion (Fig. 3f) matched a corresponding increase in MMP9-cleavable reporter signals over time (Fig. 3g).